FDA Inspection 544288 — Aquestive Therapeutics

Aquestive Therapeutics — FEI 3004395604

The FDA completed an inspection of Aquestive Therapeutics on Oct 23, 2008 in Portage, IN. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 4 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Oct 23, 2008
Fiscal Year
2009
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Portage, IN (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
121521 CFR 211.67(b)Written procedures not established/followed
191221 CFR 211.166(a)Written program not followed
202721 CFR 211.192Investigations of discrepancies, failures